These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 22211523

  • 1. Survival characteristics and prognostic variables of dogs with preclinical chronic degenerative mitral valve disease attributable to myxomatous degeneration.
    Borgarelli M, Crosara S, Lamb K, Savarino P, La Rosa G, Tarducci A, Haggstrom J.
    J Vet Intern Med; 2012; 26(1):69-75. PubMed ID: 22211523
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for coughing in dogs with naturally acquired myxomatous mitral valve disease.
    Ferasin L, Crews L, Biller DS, Lamb KE, Borgarelli M.
    J Vet Intern Med; 2013; 27(2):286-92. PubMed ID: 23398050
    [Abstract] [Full Text] [Related]

  • 3. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K, Kawamoto S, Osuga T, Morita T, Sasaki N, Morishita K, Ohta H, Takiguchi M.
    J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
    [Abstract] [Full Text] [Related]

  • 4. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease.
    Borgarelli M, Savarino P, Crosara S, Santilli RA, Chiavegato D, Poggi M, Bellino C, La Rosa G, Zanatta R, Haggstrom J, Tarducci A.
    J Vet Intern Med; 2008 Mar; 22(1):120-8. PubMed ID: 18289298
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S, Green D, Christley R, Dukes-McEwan J.
    J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2013 Jun; 27(6):1441-51. PubMed ID: 24010489
    [Abstract] [Full Text] [Related]

  • 7. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE, Falk T, Zois NE, Moesgaard SG, Häggström J, Pedersen HD, Ablad B, Nilsen HY, Olsen LH.
    J Vet Intern Med; 2012 Jun; 26(1):76-84. PubMed ID: 22151356
    [Abstract] [Full Text] [Related]

  • 8. Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs.
    Li Q, Heaney A, Langenfeld-McCoy N, Boler BV, Laflamme DP.
    BMC Vet Res; 2019 Nov 27; 15(1):425. PubMed ID: 31775756
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease.
    Borgarelli M, Abbott J, Braz-Ruivo L, Chiavegato D, Crosara S, Lamb K, Ljungvall I, Poggi M, Santilli RA, Haggstrom J.
    J Vet Intern Med; 2015 Nov 27; 29(2):569-74. PubMed ID: 25818210
    [Abstract] [Full Text] [Related]

  • 10. Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease.
    Ljungvall I, Höglund K, Carnabuci C, Tidholm A, Häggström J.
    J Vet Intern Med; 2011 Nov 27; 25(5):1036-43. PubMed ID: 21848946
    [Abstract] [Full Text] [Related]

  • 11. QT instability, an indicator of augmented arrhythmogenesis, increases with the progression of myxomatous mitral valve disease in dogs.
    Brüler BC, Jojima FS, Dittrich G, Giannico AT, Sousa MG.
    J Vet Cardiol; 2018 Aug 27; 20(4):254-266. PubMed ID: 30031743
    [Abstract] [Full Text] [Related]

  • 12. Murmur intensity in small-breed dogs with myxomatous mitral valve disease reflects disease severity.
    Ljungvall I, Rishniw M, Porciello F, Ferasin L, Ohad DG.
    J Small Anim Pract; 2014 Nov 27; 55(11):545-50. PubMed ID: 25213440
    [Abstract] [Full Text] [Related]

  • 13. Use of signal analysis of heart sounds and murmurs to assess severity of mitral valve regurgitation attributable to myxomatous mitral valve disease in dogs.
    Ljungvall I, Ahlstrom C, Höglund K, Hult P, Kvart C, Borgarelli M, Ask P, Häggström J.
    Am J Vet Res; 2009 May 27; 70(5):604-13. PubMed ID: 19405899
    [Abstract] [Full Text] [Related]

  • 14. Prognostic relevance of left cardiac enlargement in dogs with preclinical myxomatous mitral valve disease.
    Grosso G, Vezzosi T, Domenech O, Tognetti R.
    J Vet Cardiol; 2023 Feb 27; 45():50-58. PubMed ID: 36702085
    [Abstract] [Full Text] [Related]

  • 15. Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.
    Wesselowski S, Gordon SG, Fries R, Saunders AB, Sykes KT, Vitt J, Boutet B, Häggström J, Kadotani S, Stack J, Barnett BG.
    J Vet Cardiol; 2023 Dec 27; 50():1-16. PubMed ID: 37913604
    [Abstract] [Full Text] [Related]

  • 16. Echocardiographic predictors of survival in dogs with myxomatous mitral valve disease.
    Sargent J, Muzzi R, Mukherjee R, Somarathne S, Schranz K, Stephenson H, Connolly D, Brodbelt D, Fuentes VL.
    J Vet Cardiol; 2015 Mar 27; 17(1):1-12. PubMed ID: 25586168
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.
    Vereb M, Atkins CE, Adin D, Blondel T, Coffman M, Lee S, Guillot E, Ward JL.
    J Vet Intern Med; 2024 Mar 27; 38(1):51-60. PubMed ID: 37909399
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease.
    Baron Toaldo M, Romito G, Guglielmini C, Diana A, Pelle NG, Contiero B, Cipone M.
    J Vet Intern Med; 2018 May 27; 32(3):914-921. PubMed ID: 29572938
    [Abstract] [Full Text] [Related]

  • 19. The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (LOOK-Mitral registry): Baseline characteristics.
    Franchini A, Borgarelli M, Abbott JA, Menciotti G, Crosara S, Häggström J, Lahmers S, Rosenthal S, Tyrrell W.
    J Vet Cardiol; 2021 Aug 27; 36():32-47. PubMed ID: 34062479
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.
    Yuchi Y, Suzuki R, Yasumura Y, Saito T, Teshima T, Matsumoto H, Koyama H.
    J Vet Intern Med; 2023 Aug 27; 37(3):856-865. PubMed ID: 36994902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.